Matthew Brams - Dec 7, 2021 Form 4 Insider Report for Cingulate Inc. (CING)

Role
EVP and Chief Medical Officer
Signature
/s/ Shane J. Schaffer, Attorney-in-Fact
Stock symbol
CING
Transactions as of
Dec 7, 2021
Transactions value $
$0
Form type
4
Date filed
12/9/2021, 05:00 PM
Next filing
Mar 1, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CING Stock Option (right to Buy) Award $0 +4.49K $0.00 4.49K Dec 7, 2021 Common Stock 4.49K $6.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in four equal annual installments commencing on December 7, 2022.